Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients-a potential biomarker of disease activity.

about

Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients-a potential biomarker of disease activity.

Item

http://www.wikidata.org/entity/Q51067608

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Altered expression of signalli ...... biomarker of disease activity.

@en

Altered expression of signalli ...... biomarker of disease activity.

@nl

type

Item

label

Altered expression of signalli ...... biomarker of disease activity.

@en

Altered expression of signalli ...... biomarker of disease activity.

@nl

prefLabel

Altered expression of signalli ...... biomarker of disease activity.

@en

Altered expression of signalli ...... biomarker of disease activity.

@nl

P1476

Altered expression of signalli ...... biomarker of disease activity.

@en

P2093

Anne F Doyle

http://www.w3.org/2001/XMLSchema#string

Francesco Carlucci

http://www.w3.org/2001/XMLSchema#string

H Terence Cook

http://www.w3.org/2001/XMLSchema#string

Lauren Stephens

http://www.w3.org/2001/XMLSchema#string

Liz Lightstone

http://www.w3.org/2001/XMLSchema#string

Marco Castelli

http://www.w3.org/2001/XMLSchema#string

Marina Botto

http://www.w3.org/2001/XMLSchema#string

Matthew C Pickering

http://www.w3.org/2001/XMLSchema#string

Nicola McKenna

http://www.w3.org/2001/XMLSchema#string

Thomas D Cairns

http://www.w3.org/2001/XMLSchema#string

P2860

Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation

SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells

SAP is required for generating long-term humoral immunity

The 1982 revised criteria for the classification of systemic lupus erythematosus

Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.

Human TCR-alpha beta+ CD4- CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype

A novel isoform of the Ly108 gene ameliorates murine lupus.

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.

B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levels.

T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection.

P304

1206-1216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEX078

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marina Botto

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28387859

http://www.w3.org/2001/XMLSchema#string

P932

5850773

http://www.w3.org/2001/XMLSchema#string